FDA 483 - Ultrum Labs LLC - October 16, 2023

Ultrum Labs LLC, an OTC drug manufacturer in Tampa, FL, was cited with six observations during an FDA inspection. The inspection revealed significant deficiencies across quality control, data integrity, production procedures, and equipment cleaning. Key issues included inadequate raw material testing and release, failure to follow written procedures, lack of computer system controls, and absence of critical validation studies.